APO-IMIPRAMINE DIN 02406616
Health Canada record
| Active ingredient(s) | IMIPRAMINE HYDROCHLORIDE 75 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AA02 IMIPRAMINE |
| Original market date | |
| Current status date | 13-May-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IMIPRAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02406608 | APO-IMIPRAMINE | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Approved |
| 02406586 | APO-IMIPRAMINE | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Approved |
| 02406594 | APO-IMIPRAMINE | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Approved |
| 00312797 | APO-IMIPRAMINE TABLETS | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Marketed |
| 00644579 | APO-IMIPRAMINE TABLETS | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 75 MG | Marketed |
| 00360201 | APO-IMIPRAMINE TABLETS | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Marketed |
| 00326852 | APO-IMIPRAMINE TABLETS | APOTEX INC | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Marketed |
| 02546361 | JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Tablet | IMIPRAMINE HYDROCHLORIDE 75 MG | Marketed |
| 02546337 | JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Marketed |
| 02546345 | JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Marketed |
| 02546353 | JAMP IMIPRAMINE | JAMP PHARMA CORPORATION | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Marketed |
| 00371017 | IMIPRAMINE 10TAB | PRO DOC LIMITEE | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00371025 | IMIPRAMINE 25TAB | PRO DOC LIMITEE | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00456357 | IMIPRAMINE 50 TAB 50MG | PRO DOC LIMITEE | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00377910 | IMIPRAMINE HYDROCHLORIDE TABLETS 25MG | D.C. LABS LIMITED | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00377929 | IMIPRAMINE HYDROCHLORIDE TABLETS 50MG | D.C. LABS LIMITED | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00431087 | IMIPRAMINE TAB 25MG | DUCHESNAY INC | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00236748 | IMPRIL | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00405604 | IMPRIL | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | IMIPRAMINE HYDROCHLORIDE 75 MG | Cancelled Post Market |
| 00236756 | IMPRIL | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00236721 | IMPRIL | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00021504 | NOVO-PRAMINE TAB 10MG | NOVOPHARM LIMITED | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00021512 | NOVO-PRAMINE TAB 25MG | NOVOPHARM LIMITED | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00021520 | NOVO-PRAMINE TAB 50MG | NOVOPHARM LIMITED | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00726397 | PMS IMIPRAMINE TAB 10MG | PHARMASCIENCE INC | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00726303 | PMS IMIPRAMINE TAB 25MG | PHARMASCIENCE INC | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00726311 | PMS IMIPRAMINE TAB 50MG | PHARMASCIENCE INC | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00010464 | TOFRANIL 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | IMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00010472 | TOFRANIL 25MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | IMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00010480 | TOFRANIL 50MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | IMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00306487 | TOFRANIL 75MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | IMIPRAMINE HYDROCHLORIDE 75 MG | Cancelled Post Market |
International API supply for IMIPRAMINE HYDROCHLORIDE
1 valid EDQM Certificates of Suitability from 1 holders. 2 active FDA Drug Master Files.
Request a quote for APO-IMIPRAMINE